Quanterix Corp. (QTRX)
Evaluation: Based on all recent filings, financial statements, and news.
See full evaluationAsk a question about Quanterix Corp. (QTRX)
Go deeper and ask any question about QTRX
Company Performance
Current Price
as of Sep 13, 2024$12.82
P/E Ratio
N/A
Market Cap
$492.02M
Description
Quanterix Corp. engages in the development of ultra-sensitive digital immunoassay platform that advances precision health for life sciences research and diagnostics. Its products and services include Simoa Assay Kits, HD-X analyzer, SR-X Biomarker Detection System, SP-X Imaging and Analysis System, 2470 Arrayer, Simoa Accelerator Laboratory, Uman NF-Light, and Homebrew -Custom Assay Development. The company was founded by Nicholas J. Naclerio and David R. Walt in April 2007 and is headquartered in Billerica, MA.
Metrics
Overview
- HQBillerica, MA
- SectorHealth Technology
- IndustryMedical Specialties
- TickerQTRX
- Price$12.82+2.64%
Trading Information
- Market Cap$492.02M
- Float90.85%
- Average Daily Volume (1m)320,201
- Average Daily Volume (3m)423,545
- EPS-$1.04
Company
- Revenue$129.33M
- Rev Growth (1yr)10.80%
- Net Income-$9.47M
- Gross Margin58.34%
- EBITDA Margin-32.42%
- EBITDA-$11.15M
- EV$249.17M
- EV/Revenue1.93
- P/EN/A
- P/S3.80
Documents
SEC Filings
Factset Street Account